Cargando…

Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint

Topoisomerase (topo) IIα and IIβ maintain genome stability and are targets for anti-tumor drugs. In this study, we demonstrate that the decatenation checkpoint is regulated, not only by topo IIα, as previously reported, but also by topo IIβ. The decatenation checkpoint is most efficient when both is...

Descripción completa

Detalles Bibliográficos
Autores principales: Kozuki, Toshiyuki, Chikamori, Kenichi, Surleac, Marius D., Micluta, Marius A., Petrescu, Andrei J., Norris, Eric J., Elson, Paul, Hoeltge, Gerald A., Grabowski, Dale R., Porter, Andrew C.G., Ganapathi, Ram N., Ganapathi, Mahrukh K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449615/
https://www.ncbi.nlm.nih.gov/pubmed/28472494
http://dx.doi.org/10.1093/nar/gkx325
_version_ 1783239819435966464
author Kozuki, Toshiyuki
Chikamori, Kenichi
Surleac, Marius D.
Micluta, Marius A.
Petrescu, Andrei J.
Norris, Eric J.
Elson, Paul
Hoeltge, Gerald A.
Grabowski, Dale R.
Porter, Andrew C.G.
Ganapathi, Ram N.
Ganapathi, Mahrukh K.
author_facet Kozuki, Toshiyuki
Chikamori, Kenichi
Surleac, Marius D.
Micluta, Marius A.
Petrescu, Andrei J.
Norris, Eric J.
Elson, Paul
Hoeltge, Gerald A.
Grabowski, Dale R.
Porter, Andrew C.G.
Ganapathi, Ram N.
Ganapathi, Mahrukh K.
author_sort Kozuki, Toshiyuki
collection PubMed
description Topoisomerase (topo) IIα and IIβ maintain genome stability and are targets for anti-tumor drugs. In this study, we demonstrate that the decatenation checkpoint is regulated, not only by topo IIα, as previously reported, but also by topo IIβ. The decatenation checkpoint is most efficient when both isoforms are present. Regulation of this checkpoint and sensitivity to topo II-targeted drugs is influenced by the C-terminal domain (CTD) of the topo II isoforms and by a conserved non-catalytic tyrosine, Y640 in topo IIα and Y656 in topo IIβ. Deletion of most of the CTD of topo IIα, while preserving the nuclear localization signal (NLS), enhances the decatenation checkpoint and sensitivity to topo II-targeted drugs. In contrast, deletion of most of the CTD of topo IIβ, while preserving the NLS, and mutation of Y640 in topo IIα and Y656 in topo IIβ inhibits these activities. Structural studies suggest that the differential impact of the CTD on topo IIα and topo IIβ function may be due to differences in CTD charge distribution and differential alignment of the CTD with reference to transport DNA. Together these results suggest that topo IIα and topo IIβ cooperate to maintain genome stability, which may be distinctly modulated by their CTDs.
format Online
Article
Text
id pubmed-5449615
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-54496152017-06-05 Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint Kozuki, Toshiyuki Chikamori, Kenichi Surleac, Marius D. Micluta, Marius A. Petrescu, Andrei J. Norris, Eric J. Elson, Paul Hoeltge, Gerald A. Grabowski, Dale R. Porter, Andrew C.G. Ganapathi, Ram N. Ganapathi, Mahrukh K. Nucleic Acids Res Nucleic Acid Enzymes Topoisomerase (topo) IIα and IIβ maintain genome stability and are targets for anti-tumor drugs. In this study, we demonstrate that the decatenation checkpoint is regulated, not only by topo IIα, as previously reported, but also by topo IIβ. The decatenation checkpoint is most efficient when both isoforms are present. Regulation of this checkpoint and sensitivity to topo II-targeted drugs is influenced by the C-terminal domain (CTD) of the topo II isoforms and by a conserved non-catalytic tyrosine, Y640 in topo IIα and Y656 in topo IIβ. Deletion of most of the CTD of topo IIα, while preserving the nuclear localization signal (NLS), enhances the decatenation checkpoint and sensitivity to topo II-targeted drugs. In contrast, deletion of most of the CTD of topo IIβ, while preserving the NLS, and mutation of Y640 in topo IIα and Y656 in topo IIβ inhibits these activities. Structural studies suggest that the differential impact of the CTD on topo IIα and topo IIβ function may be due to differences in CTD charge distribution and differential alignment of the CTD with reference to transport DNA. Together these results suggest that topo IIα and topo IIβ cooperate to maintain genome stability, which may be distinctly modulated by their CTDs. Oxford University Press 2017-06-02 2017-05-02 /pmc/articles/PMC5449615/ /pubmed/28472494 http://dx.doi.org/10.1093/nar/gkx325 Text en © The Author(s) 2017. Published by Oxford University Press on behalf of Nucleic Acids Research. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Nucleic Acid Enzymes
Kozuki, Toshiyuki
Chikamori, Kenichi
Surleac, Marius D.
Micluta, Marius A.
Petrescu, Andrei J.
Norris, Eric J.
Elson, Paul
Hoeltge, Gerald A.
Grabowski, Dale R.
Porter, Andrew C.G.
Ganapathi, Ram N.
Ganapathi, Mahrukh K.
Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint
title Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint
title_full Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint
title_fullStr Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint
title_full_unstemmed Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint
title_short Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint
title_sort roles of the c-terminal domains of topoisomerase iiα and topoisomerase iiβ in regulation of the decatenation checkpoint
topic Nucleic Acid Enzymes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449615/
https://www.ncbi.nlm.nih.gov/pubmed/28472494
http://dx.doi.org/10.1093/nar/gkx325
work_keys_str_mv AT kozukitoshiyuki rolesofthecterminaldomainsoftopoisomeraseiiaandtopoisomeraseiibinregulationofthedecatenationcheckpoint
AT chikamorikenichi rolesofthecterminaldomainsoftopoisomeraseiiaandtopoisomeraseiibinregulationofthedecatenationcheckpoint
AT surleacmariusd rolesofthecterminaldomainsoftopoisomeraseiiaandtopoisomeraseiibinregulationofthedecatenationcheckpoint
AT miclutamariusa rolesofthecterminaldomainsoftopoisomeraseiiaandtopoisomeraseiibinregulationofthedecatenationcheckpoint
AT petrescuandreij rolesofthecterminaldomainsoftopoisomeraseiiaandtopoisomeraseiibinregulationofthedecatenationcheckpoint
AT norrisericj rolesofthecterminaldomainsoftopoisomeraseiiaandtopoisomeraseiibinregulationofthedecatenationcheckpoint
AT elsonpaul rolesofthecterminaldomainsoftopoisomeraseiiaandtopoisomeraseiibinregulationofthedecatenationcheckpoint
AT hoeltgegeralda rolesofthecterminaldomainsoftopoisomeraseiiaandtopoisomeraseiibinregulationofthedecatenationcheckpoint
AT grabowskidaler rolesofthecterminaldomainsoftopoisomeraseiiaandtopoisomeraseiibinregulationofthedecatenationcheckpoint
AT porterandrewcg rolesofthecterminaldomainsoftopoisomeraseiiaandtopoisomeraseiibinregulationofthedecatenationcheckpoint
AT ganapathiramn rolesofthecterminaldomainsoftopoisomeraseiiaandtopoisomeraseiibinregulationofthedecatenationcheckpoint
AT ganapathimahrukhk rolesofthecterminaldomainsoftopoisomeraseiiaandtopoisomeraseiibinregulationofthedecatenationcheckpoint